COVID-19 in immunocompromised patients: A systematic review of cancer, hematopoietic cell and solid organ transplant patients
Open Access
- 3 February 2021
- journal article
- review article
- Published by Elsevier BV in Journal of Infection
- Vol. 82 (3), 329-338
- https://doi.org/10.1016/j.jinf.2021.01.022
Abstract
No abstract availableKeywords
This publication has 141 references indexed in Scilit:
- How to perform a meta-analysis with R: a practical tutorialEvidence-Based Mental Health, 2019
- Immunodeficiency DisordersPediatrics in Review, 2019
- PRISMA Extension for Scoping Reviews (PRISMA-ScR): Checklist and ExplanationAnnals of Internal Medicine, 2018
- Solid organ transplantation in the 21st centuryAnnals of Translational Medicine, 2018
- Hematopoietic stem cell transplantation in its 60s: A platform for cellularScience Translational Medicine, 2018
- Virus-Specific T Cells for the Immunocompromised PatientFrontiers in Immunology, 2017
- Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantationScience Translational Medicine, 2015
- What's fueling the biotech engine—2012 to 2013Nature Biotechnology, 2014
- Immune-Modulating Drugs and Hypomethylating Agents to Prevent or Treat Relapse after Allogeneic Stem Cell TransplantationTransplantation and Cellular Therapy, 2013
- Cancer Facts & Figures 2012. American Cancer Society (ACS)Journal of Consumer Health on the Internet, 2012